Objective: To estimate the risk of early‐onset neonatal sepsis among newborns of mothers with chorioamnionitis and/or bacterial colonisation in Dhaka.Methods: We conducted a cohort study at a maternity centre following 600 mother–newborn pairs. Women with a positive bacterial vaginal culture or positive Group B streptococcus (GBS) rectal culture during labour were classified as colonised. Women with placental histopathology demonstrating signs of maternal or foetal inflammation were classified as having chorioamnionitis. Newborns were followed over the first 7 days of life. The primary outcome measure was physician or community health worker diagnosis of neonatal sepsis following modified World Health Organization Integrated Management of Childhood Illnesses criteria. Survival analysis was conducted with non‐parametric, parametric and semiparametric models.Results: Of the 600 mother–newborn pairs, 12.8% of newborns were diagnosed with early‐onset sepsis. Five hundred and forty‐three women had both colonisation and chorioamnionitis data, 55.4% of mothers were non‐exposed, 31.7% were only colonised and 12.9% had chorioamnionitis regardless of colonisation status.After adjusting for birthweight, sex, maternal characteristics and wealth, newborns of only colonised mothers developed sepsis 63% faster and had a 71% higher risk of developing sepsis than their non‐exposed counterparts (RT = 0.37, 95% CI 0.14–1.03; RH = 1.71, 95% CI 1.00–2.94). Newborns of mothers with chorioamnionitis developed sepsis 74% faster and had a 111% higher risk of developing sepsis (RT = 0.26, 95% CI 0.07–0.94; RH = 2.11, 95% CI 1.06–4.21).Conclusions: Newborns born to mothers with colonisation or chorioamnionitis developed sepsis faster and were at higher risk of developing sepsis in Dhaka.
With resistance to current frontline antimalarials spreading globally, new drug candidates need to be discovered to populate the antimalarial drug development pipeline. We previously screened the Medicines for Malaria Venture Pathogen Box for compounds that prevent Plasmodium falciparum parasites from exiting and invading human erythrocytes, steps essential for the proliferation of parasites in the blood, which causes disease. Compound MMV020512 (M-512) was identified in this screen and live cell imaging here established that it does not specifically inhibit invasion but likely inhibits intraerythrocytic parasite growth. M-512 resistance selection in parasites led to the identification of mutations in the membrane protease Pf ROM8 and the cation ion channel Pf CSC1. Pf ROM8 was validated as a target of M-512 when a L562R putative resistance mutation was engineered into wildtype parasites reproducing the resistance phenotype. Knockdown of wildtype Pf ROM8, the L562R mutant and CSC1 reduced parasite growth, indicating the proteins are functionally important. Counterintuitively, the Pf ROM8 and Pf CSC1 knockdown parasites became more resistant to M-512 suggesting that the compound is an agonist of both proteins which may form a functional complex and that dysregulation of this complex is deleterious to parasite growth.